Adverum Biotechnologies (NASDAQ: ADVM)
Adverum Biotechnologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Adverum Biotechnologies Company Info
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
News & Analysis
Why Adverum Biotechnologies Stock Sank in May
The uncertainty over the biotech's lead clinical asset weighed on its shares last month.
Why Adverum Biotechnologies Stock Is Imploding Today
Investors are running for the hills following the company's latest clinical update.
3 Best Healthcare Stocks to Buy in May
AbbVie, Adverum Biotechnologies, and Heron Therapeutics could all be gearing up for a strong May. Here's why.
Here's Why Adverum Biotechnologies Is Soaring Today
The company's experimental gene therapy for a common cause of blindness showed promise in a clinical trial.
Why Adverum Biotechnologies Stock Is Soaring Today
Adverum's lead gene therapy candidate continues to impress in its early-stage trial.
Here's Why Adverum Biotechnologies Is Soaring Today
Interim results from an early-stage study of its wet age-related macular degeneration treatment look promising.
3 Soaring Biotech Stocks to Watch in December
Here's how they could keep on rocketing higher.
3 Blindness-Fighting Biotech Stocks That Could Surge This Week
Here's what to look out for at the American Academy of Ophthalmology's annual meeting later this week.
Valuation
Earnings Transcripts
Adverum Biotechnologies, Inc. (ADVM) Q4 2020 Earnings Call Transcript
ADVM earnings call for the period ending December 31, 2020.
Adverum Biotechnologies, Inc. (ADVM) Q2 2020 Earnings Call Transcript
ADVM earnings call for the period ending June 30, 2020.
Adverum Biotechnologies, Inc. (ADVM) Q1 2020 Earnings Call Transcript
ADVM earnings call for the period ending March 31, 2020.
Adverum Biotechnologies, Inc. (ADVM) Q4 2019 Earnings Call Transcript
ADVM earnings call for the period ending December 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.